Both companies will focus on technology integration and marketing to ensure the successful adoption of the integrated solution.

Single-atom editing under mild conditions was achieved for heterocyclics, thanks to a new oxygen-to-nitrogen photocatalyst.

Mark Munch, president of Bruker Nano Group, talks to GEN about Bruker’s reasons for acquiring Nanostring and their vision for ...

Researchers envision that any biology lab should be able to use the technique at low cost as it relies on standard, off-the-shelf chemicals and common equipment ...

The company claims to have decoded human cell rejuvenation and identified potential gene targets for therapies that treat ...

Among the newer initiatives was developing the lab of the future; next-gen biology; AI and sustainability. The new facility ...

Improving global diversity of global datasets will enable researchers to better serve underrepresented groups and advance our ...

Illumina unveiled its MiSeq i100 Series of sequencing systems: two new benchtop instruments, MiSeq i100 and MiSeq i100 Plus ...

The company reflects on their latest IND approval, the evolution of their end-to-end drug discovery platform, and what’s next ...

Findings implied more generally that the effects of dietary restriction on health and lifespan may be partially ...

The company is developing molecules that boost the ubiquitin-independent protein degradation activity of 20S proteasomes in ...

Researchers suggest findings could help to pinpoint cell types most vulnerable to conditions such as schizophrenia, and ...